Guangdong Marubi Biotechnology Stock EBITDA
| 603983 Stock | 27.63 0.18 0.65% |
Guangdong Marubi Biotechnology fundamentals help investors to digest information that contributes to Guangdong Marubi's financial success or failures. It also enables traders to predict the movement of Guangdong Stock. The fundamental analysis module provides a way to measure Guangdong Marubi's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Guangdong Marubi stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | 212.7 M | 348 M |
Guangdong | EBITDA |
Guangdong Marubi Biotechnology Company EBITDA Analysis
Guangdong Marubi's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Guangdong Marubi EBITDA | 277.35 M |
Most of Guangdong Marubi's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Guangdong Marubi Biotechnology is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Guangdong Ebitda
Ebitda |
|
According to the company disclosure, Guangdong Marubi Biotechnology reported earnings before interest,tax, depreciation and amortization of 277.35 M. This is 81.69% lower than that of the Personal Care Products sector and 88.44% lower than that of the Consumer Staples industry. The ebitda for all China stocks is 92.89% higher than that of the company.
Guangdong EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Guangdong Marubi's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Guangdong Marubi could also be used in its relative valuation, which is a method of valuing Guangdong Marubi by comparing valuation metrics of similar companies.Guangdong Marubi is currently under evaluation in ebitda category among its peers.
Guangdong Fundamentals
| Return On Equity | 0.1 | ||||
| Return On Asset | 0.039 | ||||
| Profit Margin | 0.12 % | ||||
| Operating Margin | 0.10 % | ||||
| Current Valuation | 9.55 B | ||||
| Shares Outstanding | 401 M | ||||
| Shares Owned By Insiders | 80.79 % | ||||
| Shares Owned By Institutions | 7.46 % | ||||
| Price To Book | 3.30 X | ||||
| Price To Sales | 4.22 X | ||||
| Revenue | 2.23 B | ||||
| Gross Profit | 1.14 B | ||||
| EBITDA | 277.35 M | ||||
| Net Income | 259.42 M | ||||
| Total Debt | 100.07 M | ||||
| Book Value Per Share | 8.42 X | ||||
| Cash Flow From Operations | 338.02 M | ||||
| Earnings Per Share | 0.82 X | ||||
| Target Price | 31.19 | ||||
| Number Of Employees | 1.1 K | ||||
| Beta | 0.21 | ||||
| Market Capitalization | 11.16 B | ||||
| Total Asset | 4.45 B | ||||
| Retained Earnings | 1.99 B | ||||
| Working Capital | 1.52 B | ||||
| Net Asset | 4.45 B | ||||
| Last Dividend Paid | 0.52 |
About Guangdong Marubi Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Guangdong Marubi Biotechnology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Guangdong Marubi using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Guangdong Marubi Biotechnology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Guangdong Stock
Guangdong Marubi financial ratios help investors to determine whether Guangdong Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Guangdong with respect to the benefits of owning Guangdong Marubi security.